Category: Wellness (Page 15 of 116)

Early Birds Fare Better Than Night Owls

Since society is built around a morning oriented schedule it stands to reason that late sleepers feel left behind during the day.

Overall, early risers are happier.

Scientists are not sure if the feelings of happiness are the result of rest, exposure to light or the body’s bio-chemical response to sleep.

By age 60, most people are morning types, the researchers found. Only about 7 percent of young adults are morning larks, but as the population ages, this switches — in the older years only about 7 percent of the population are still night owls.
“We found that older adults reported greater positive emotion than younger adults, and older adults were more likely to be morning-type people than younger adults,” Biss said. “The ‘morningness’ was associated with greater happiness emotions in both age groups.”

Donna Shalala Discuses A Major Threat To Our National Security

Visit msnbc.com for breaking news, world news, and news about the economy

Obesity takes a huge financial toll on the nation.

Chronic illnesses caused by obesity are crippling our healthcare system.

How can we turn this around?

Couples Who Share A Bed Are Healthier

Getting cuddly can be good for your health.

Even when you consider tossing and turning, snoring and blanket hogs, the benefits of nighttime snuggling outweigh the annoyances.

While the science is in the early stages, one hypothesis suggests that by promoting feelings of safety and security, shared sleep in healthy relationships may lower levels of cortisol, a stress hormone. Sharing a bed may also reduce cytokines, involved in inflammation, and boost oxytocin, the so-called love hormone that is known to ease anxiety and is produced in the same part of the brain responsible for the sleep-wake cycle. So even though sharing a bed may make people move more, “the psychological benefits we get having closeness at night trump the objective costs of sleeping with a partner,” Dr. Troxel says.

Experimental New Drug To Fight Breast Cancer

For women with faced with HER2-positive metastatic breast cancer trastuzumab emtansine, commonly referred to as T-DM1, will offer a very important therapeutic option.

The drug, trastuzumab emtansine, commonly referred to as T-DM1, appears to be superior to the standard treatment for women with advanced HER2-positive breast cancer. Researchers are presenting the results of a large three-year clinical trial Sunday at the 2012 American Society of Clinical Oncology conference in Chicago.

This two pronged approach to treating cancer offers an effective result with fewer side affects than traditional treatments.

Because the drug is delivered directly to the cancer and not into the blood stream the immune system has the opportunity to help fight the cancer.

« Older posts Newer posts »

© 2026 MedClient.com

Theme by Anders NorenUp ↑